NAD+ boosters are the latest anti-aging trend in Hollywood, with celebrities and wellness influencers adopting them. Despite their popularity, the FDA has prohibited many of these supplements while they are still undergoing clinical trials. The shift towards NAD+ boosters follows a surge in the global market for weight-loss drugs, driven by companies like Novo Nordisk and Eli Lilly. However, the high demand for GLP-1 medications is causing supply issues for type 2 diabetic patients.